Racial Disparities in Utilization of Specialist Care and Medications in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Racial Disparities in Utilization of Specialist Care and Medications in Inflammatory Bowel Disease

Published:2010-10 Issue:10 Volume:105 Page:2202-2208
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Nguyen Geoffrey C,LaVeist Thomas A,Harris Mary L,Wang Ming-Hsi,Datta Lisa W,Brant Steven R

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2010202.pdf

Reference33 articles.

1. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.;Lichtenstein;Gastroenterology,2006

2. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn disease: results from the CHARM study.;Feagan;Gastroenterology,2008

3. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohns disease.;Lichtenstein;Gastroenterology,2005

4. Infliximab decreases resource use among patients with Crohns disease.;Rubenstein;J Clin Gastroenterol,2002

5. Maintenance infliximab for Crohns disease: the ACCENT I randomised trial.;Hanauer;Lancet,2002

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost of Inflammatory Bowel Disease Care – How to Make it Sustainable;Clinical Gastroenterology and Hepatology;2024-08

2. Mucosal Healing Among Black and White Patients With Inflammatory Bowel Disease;Clinical and Translational Gastroenterology;2024-07-15

3. Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease;Digestive Diseases and Sciences;2024-07-04

4. Inflammatory Bowel Disease Population Analyzer Tool for Health Systems (IBD PATH): a case study risk stratifying patients with inflammatory bowel disease for clinical outcomes;Journal of Hospital Management and Health Policy;2024-06

5. Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic;World Journal of Gastroenterology;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3